HOB Biotech Group Corp.,Ltd

688656

CNE100004C37

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. Other stock markets 18:00:00 2024-06-02 EDT			5-day change	1st Jan Change
23.96 ^CNY	-3.31%		-0.75%	-31.07%

04-28	HOB Biotech Group Corp.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-11	HOB Biotech Group Corp.,Ltd announces an Equity Buyback for CNY 30 million worth of its shares.	CI

HOB Biotech Group Corp., Ltd has completed an IPO in the amount of CNY 555.859161 million.

January 07, 2021 at 12:00 am

HOB Biotech Group Corp., Ltd has completed an IPO in the amount of CNY 555.859161 million. Security Name: A Shares Security Type: Common Stock Securities Offered: 15,764,582 PriceRange: CNY 35.26

Latest news about HOB Biotech Group Corp.,Ltd

HOB Biotech Group Corp.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	04-28	CI
HOB Biotech Group Corp.,Ltd announces an Equity Buyback for CNY 30 million worth of its shares.	03-10	CI
HOB Biotech Group Corp.,Ltd authorizes a Buyback Plan.	03-07	CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	02-02	CI
Certain A Shares of HOB Biotech Group Corp., Ltd are subject to a Lock-Up Agreement Ending on 14-JAN-2024.	01-13	CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
HOB Biotech Inks Deal With Spain’s Inmunotek to Distribute Allergy Treatment in China	23-09-05	MT
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-24	CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27	CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-30	CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-24	CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-27	CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-25	CI
HOB Biotech Group Corp.,Ltd(SHSE:688656) added to Shanghai Stock Exchange Composite Index	22-01-21	CI
HOB Biotech Group Corp.,Ltd(SHSE:688656) added to Shanghai Stock Exchange A Share Index	22-01-21	CI
Certain A Shares of HOB Biotech Group Corp., Ltd are subject to a Lock-Up Agreement Ending on 14-JAN-2022.	22-01-13	CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-20	CI
Hob Biotech Group Corp.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-18	CI
Hob Biotech Group Corp.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-21	CI
HOB Biotech Group Corp., Ltd Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-14	CI
HOB Biotech : Surges 112% in Shanghai Trading Debut	21-01-13	MT
Hob Biotech Group Corp., Ltd Reports Earnings Results for the Full Year Ended December 31, 2019	21-01-07	CI
HOB Biotech Group Corp., Ltd has completed an IPO in the amount of CNY 555.859161 million.	21-01-07	CI
HOB Biotech Group Corp., Ltd has filed an IPO.	20-04-29	CI

Chart HOB Biotech Group Corp.,Ltd

Duration

Period

More charts

HOB Biotech Group Corp Ltd is a China-based company primarily engaged in the research and development, production and sales of in vitro diagnostic reagents. The Company provides two categories of products: allergy testing products and self-immune testing products. Its detection techniques include qualitative detection techniques such as enzyme-linked immunosorbent assay, and quantitative detection techniques such as enzyme-linked immunoassay capture method and nano-magnetic particle chemiluminescence method. The brands of allergy testing products include Oboke, Fubok, Shibok and Shibok Plus. The self-immune testing product brands include Norbok and Nabok. It is also engaged in the provision of reagent supporting testing instruments and others. The Company conducts its businesses in the domestic market.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-22 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
HOB BIOTECH GROUP CORP.,LTD	-31.07%	215M
ABBOTT LABORATORIES	-6.43%	178B
MEDTRONIC PLC	-1.06%	107B
BECTON, DICKINSON AND COMPANY	-2.42%	67.04B
DEXCOM, INC.	-7.44%	47.23B
CENCORA, INC.	+11.51%	44.62B
HOYA CORPORATION	+9.25%	42.5B
METTLER-TOLEDO INTERNATIONAL, INC.	+14.86%	29.99B
TERUMO CORPORATION	+15.97%	25.22B
WEST PHARMACEUTICAL SERVICES, INC.	-7.51%	24.14B